Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 10/20 | 0.54 |
| ▸ | MGAM | O43451 | 9/20 | 0.54 |
| ▸ | AMY1A | P0DUB6 | 9/20 | 0.54 |
| ▸ | SI | P14410 | 9/20 | 0.54 |
| ▸ | MGAM2 | Q2M2H8 | 9/20 | 0.54 |
| ▸ | F2 | P00734 | 2/20 | 0.54 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.54 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | F12 | P00748 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3544941 | 0.86 | EGLN3 (0.60) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL13604208 | 0.86 | GAA (0.58) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL535388 | 0.86 | KMT2A (0.59) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL23780256 | 0.83 | KMT2A (0.62) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL2489579 | 0.83 | KMT2A (0.55) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL30219683 | 0.82 | GAA (0.58) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL13134139 | 0.82 | GAA (0.58) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL2376575 | 0.82 | KMT2A (0.54) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL535030 | 0.82 | ASAH1 (0.64) | KMT2AHPGDMAPTHSD17B10ALOX15 | |
| SCHEMBL9100157 | 0.81 | KMT2A (0.54) | KMT2AHPGDMAPTHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9683009-B2 | Bone-selective osteogenic oxysterol-bone targeting agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-20 | — | — | US | disclosed |
| US-20160159850-A1 | BONE-SELECTIVE OSTEOGENIC OXYSTEROL-BONE TARGETING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159850-A1 | BONE-SELECTIVE OSTEOGENIC OXYSTEROL-BONE TARGETING AGENTS | SOST, BMP2, BMP1 | KMT2A 4688/4885HPGD 548/4885MAPT 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.